Anna Pasetto

• Mensali, Nadia; Joaquina, Sandy Roxane; Montlaur, Constance De; Casey, Nicholas Paul; Nesset, Thomas Olsen & Myklebost, Ola [Vis alle 12 forfattere av denne artikkelen] (2026). Pre-clinical validation of OSCAR-3 mRNA-based CAR T cells for targeting osteosarcomas. Cytotherapy. ISSN 1465-3249. 28(12). doi: 10.1016/j.jcyt.2026.102930.
• Mazzotti, Lucia; Souza, Patricia Borges de; Azzali, Irene; Angeli, Davide; Nanni, Oriana & Sambri, Vittorio [Vis alle 17 forfattere av denne artikkelen] (2025). Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 Severity. HLA. ISSN 2059-2302. 105(1). doi: 10.1111/tan.70011. Fulltekst i vitenarkiv
• Maravelia, Panagiota; Yao, Haidong; Cai, Curtis; Silva, Daniela Nascimento; Fransson, Jennifer & Nilsson, Ola B [Vis alle 17 forfattere av denne artikkelen] (2025). Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation. Gut. ISSN 0017-5749. 74, s. 1125–1136. doi: 10.1136/gutjnl-2024-334148. Fulltekst i vitenarkiv
• Gaimari, Anna; Lucia, Anna De; Nicolini, Fabio; Mazzotti, Lucia; Maltoni, Roberta & Rughi, Giovanna [Vis alle 20 forfattere av denne artikkelen] (2024). Significant Advancements and Evolutions in Chimeric Antigen Receptor Design. International Journal of Molecular Sciences. ISSN 1661-6596. 25(22). doi: 10.3390/ijms252212201. Fulltekst i vitenarkiv
• Chiavelli, Chiara; Prapa, Malvina; Rovesti, Giulia; Silingardi, Marco; Neri, Giovanni & Pugliese, Giuseppe [Vis alle 23 forfattere av denne artikkelen] (2024). Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma. NPJ precision oncology. 8(1). doi: 10.1038/s41698-024-00506-z. Fulltekst i vitenarkiv
• Silva, D.N.; Chrobok, M.; Ahlén, G.; Blomberg, P.; Sällberg, M. & Pasetto, Anna (2022). ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing. Immuno-Oncology and Technology (IOTECH). 16. doi: 10.1016/j.iotech.2022.100099. Fulltekst i vitenarkiv

Se alle arbeider i NVA

• Gjerdingen, Thea Johanne; Meyer, Saskia; Weis-Banke, Stine Emilie; Hansen, Marie; Ma, Jing & Yu, Di [Vis alle 13 forfattere av denne artikkelen] (2026). InsighT-1: Translating an academic TCR program into a GMP-compliant cell therapy for TdT+ ALL/LBL. Fulltekst i vitenarkiv
• Gjerdingen, Thea Johanne; Meyer, Saskia; Weis-Banke, Stine Emilie; Hansen, Marie; Ma, Jing & Yu, Di [Vis alle 13 forfattere av denne artikkelen] (2026). INSIGHT-1: TRANSLATING AN ACADEMIC TCR PROGRAM INTO A GMP-COMPLIANT CELL THERAPY FOR TdT+ ALL/LBL. Cytotherapy. ISSN 1465-3249. 28(5), s. 102861–102861. doi: 10.1016/j.jcyt.2026.102861. Fulltekst i vitenarkiv
• Pasetto, Anna & Lu, Yong-Chen (2023). Editorial: Personalized immunotherapy for cancer. Frontiers in Oncology. 13. doi: 10.3389/fonc.2023.1171907. Fulltekst i vitenarkiv

Se alle arbeider i NVA